Approval · Notice of Compliance 9091 · 2007
ATRIPLA: Notice of Compliance 9091
Issued October 15, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9091
- Date
- October 15, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATRIPLA | 02300699 | Cancelled Post Market |
Medicinal ingredients
- EFAVIRENZ 600 MG per TAB
- TENOFOVIR DISOPROXIL FUMARATE 300 MG per TAB
- EMTRICITABINE 200 MG per TAB